- Home
- GXAI vs CNSP Comparison
GXAI vs CNSP Comparison
Compare GXAI & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GXAI | CNSP |
|---|---|---|
| Founded | 2021 | 2017 |
| Country | United States | United States |
| Employees | 3 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6M | 8.5M |
| IPO Year | 2022 | 2019 |
Fundamental Metrics
Financial Performance| Metric | GXAI | CNSP |
|---|---|---|
| Price | $0.58 | $5.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | ★ 227.7K | 5.5K |
| Earning Date | 05-14-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 71.35 | 8.03 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,933,030.00 | N/A |
| Revenue This Year | $271.23 | N/A |
| Revenue Next Year | $36.32 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 47901.74 | N/A |
| 52 Week Low | $0.59 | $1.90 |
| 52 Week High | $2.63 | $10.59 |
Technical Indicators
Market Signals| Indicator | GXAI | CNSP |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 42.31 |
| Support Level | N/A | $5.15 |
| Resistance Level | N/A | $5.53 |
| Average True Range (ATR) | 0.00 | 0.17 |
| MACD | 0.00 | -0.10 |
| Stochastic Oscillator | 0.00 | 17.56 |
Price Performance
Historical ComparisonAbout GXAI Gaxos.ai Inc.
Gaxos.AI Inc is a technology company focused on reshaping the way people interact with artificial intelligence across everyday life and high-impact industries. It is engaged in building a portfolio of AI-powered solutions designed to make advanced technology more practical, accessible, and transformative. The company's portfolio spans defense, health and wellness, entertainment, and productivity - bringing intelligent tools to markets where innovation can drive meaningful real-world outcomes. It operates as a single operating segment technology-based company that is developing applications aimed at redefining the way it utilizes artificial intelligence (AI) to optimize the user experience.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.